BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23269260)

  • 41. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
    Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Complete Response in Far-Advanced Esophageal Cancer Treated with Induction Chemotherapy Followed by Definitive Chemoradiotherapy].
    Kaburagi T; Harada H; Koizumi W; Aga K; Watanabe H; Seki H; Yasui N; Sakata M; Matsumoto H; Shimada A
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1103-6. PubMed ID: 26469169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response evaluation with endoscopic ultrasound and computed tomography in esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    Chang WL; Wang WL; Chung TJ; Lin FC; Yen CJ; Lai WW; Yang HB; Sheu BS
    J Gastroenterol Hepatol; 2015 Mar; 30(3):463-9. PubMed ID: 25088453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
    Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
    Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoradiation for small cell esophageal carcinoma: report of 11 cases from multi-institution experience.
    Atsumi K; Shioyama Y; Nomoto S; Ohga S; Toba T; Sasaki T; Kunitake N; Yoshitake T; Nakamura K; Honda H
    J Radiat Res; 2010; 51(1):15-20. PubMed ID: 19755801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extrapulmonary Small Cell Carcinoma - a Case Series of Oropharyngeal and Esophageal Primary Sites Treated with Chemo-Radiotherapy.
    Sahai P; Baghmar S; Nath D; Arora S; Bhasker S; Gogia A; Sikka K; Kumar R; Chander S
    Asian Pac J Cancer Prev; 2015; 16(16):7025-9. PubMed ID: 26514485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
    Hurmuzlu M; Monge OR; Smaaland R; Viste A
    Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Esophageal Metastases from Breast Carcinoma: a Rare Delayed Metastases After 15 Years.
    Kumar S; Kumar R; Gogia A; Arava S; Tripathi M
    J Gastrointest Cancer; 2019 Sep; 50(3):674-677. PubMed ID: 29717415
    [No Abstract]   [Full Text] [Related]  

  • 49. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
    Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.
    McNamara MJ; Adelstein DJ; Bodmann JW; Greskovich JF; Ives DI; Mason DP; Murthy SC; Rice TW; Saxton JP; Sohal D; Stephans K; Rodriguez CP; Videtic GM; Rybicki LA
    J Thorac Oncol; 2014 Oct; 9(10):1561-7. PubMed ID: 25170643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Three-Year Survival after Lymphadenectomy for Residual Lymph Node Metastasis of Esophageal Cancer with Invasion into the Trachea and Carotid Artery after Chemoradiotherapy - A Case Report].
    Odagiri K; Yamazaki M; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):2006-2008. PubMed ID: 29394849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term survival of a patient with esophageal cancer with brain metastasis after multidisciplinary therapy - a case report].
    Yamamoto Y; Tanaka H; Maruyama T; Matsuzaki H; Natsume T; Miyazaki A; Satoh Y; Satsuka T; Yoshioka T; Kanada Y; Otsuka R; Yanagihara A; Yokoyama M; Kobayashi T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2006-9. PubMed ID: 25731404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case report of small cell carcinoma of the esophagus successfully treated by irinotecan and cisplatin].
    Nagahama T; Ando M; Ohbu M; Ami K; Ganno H; Taira M; Ito T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1869-71. PubMed ID: 17212131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Two cases of complete response for cStage I( T1bN0M0) esophageal carcinoma treated with chemoradiation therapy].
    Nishigaki T; Okada K; Ebisui C; Wada Y; Kato R; Makino S; Owada Y; Murakami M; Yanagisawa T; Okamura S; Murata K; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2107-9. PubMed ID: 23267992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery .
    Gill PG; Denham JW; Jamieson GG; Devitt PG; Yeoh E; Olweny C
    J Clin Oncol; 1992 Jul; 10(7):1037-43. PubMed ID: 1607911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of surgery in the management and prognosis of limited-stage small cell carcinoma of the esophagus.
    Xie MR; Xu SB; Sun XH; Ke L; Mei XY; Liu CQ; Ma DC
    Dis Esophagus; 2015 Jul; 28(5):476-82. PubMed ID: 24787553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
    Ishikura S; Nihei K; Ohtsu A; Boku N; Hironaka S; Mera K; Muto M; Ogino T; Yoshida S
    J Clin Oncol; 2003 Jul; 21(14):2697-702. PubMed ID: 12860946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical results of treatment of advanced esophageal carcinoma with hyperthermia in combination with chemoradiotherapy.
    Sakamoto T; Katoh H; Shimizu T; Yamashita I; Takemori S; Tazawa K; Fujimaki M
    Chest; 1997 Dec; 112(6):1487-93. PubMed ID: 9404743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.